George Chkhenkeli

Learn More
BACKGROUND The SCID-hu Thy/Liv mouse model of HIV-1 infection is a useful platform for the preclinical evaluation of antiviral efficacy in vivo. We performed this study to validate the model with representatives of all four classes of licensed antiretrovirals. METHODOLOGY/PRINCIPAL FINDINGS Endpoint analyses for quantification of Thy/Liv implant viral(More)
  • 1